A scoping review on aging and cardiovascular diseases - Molecular mediators and artificial intelligence-based advanced diagnostic methods [0.03%]
关于衰老与心血管疾病分子介质及人工智能辅助诊断方法的综述研究
Antonio M Sudoso,Lorenzo Ciarpaglini,Diego Scuppa et al.
Antonio M Sudoso et al.
Background: Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, and their risk increases with age. Biological age reflects physiological decline more accurately than chronological age and may i...
cAMP production secondary to A2A adenosine receptor activation as a biomarker of ischemia-reperfusion process: A comparative pilot study between CABG and PCI [0.03%]
由A2A腺苷受体激活引起的环磷腺苷生成作为缺血-再灌注过程的生物标志物：冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较研究
Pierre Deharo,Vlad Gariboldi,Marion Marlinge et al.
Pierre Deharo et al.
Background: Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are standard revascularization strategies for chronic coronary syndrome (CCS). However, their effects on myocardial reperfusi...
High four-pillar guideline-directed medical therapy adoption in heart failure with reduced ejection fraction: A tertiary-centre registry from eastern India, 2019-2024 [0.03%]
2019至2024年东印度地区一家三级医疗中心射血分数降低的心力衰竭患者四联指南指导医学治疗的采用率： Registry报告
Suyash Tripathi
Suyash Tripathi
Background: Whether dedicated tertiary heart-failure programmes in low- and middle-income countries can approach guideline-directed medical therapy (GDMT) targets, and whether temporal trends reflect prescribing optimisat...
In-hospital outcomes of valve-in-valve vs. native valve transcatheter aortic valve implantation in Brazil: A propensity-matched analysis [0.03%]
巴西经导管主动脉瓣植入术中自体瓣膜与人工瓣膜的院内结局：倾向匹配分析
Pedro Calomeni,Marcella Abizaid,Fernando Bernardi et al.
Pedro Calomeni et al.
Introduction: Transcatheter aortic valve implantation (TAVI) has become the standard of care for elderly patients with severe aortic stenosis. While valve-in-valve TAVI (ViV-TAVI) offers a less invasive alternative to red...
Impaired alveolar diffusing capacity as an underrecognized mechanism of dyspnea in HFpEF [0.03%]
射血分数保留型心力衰竭患者呼吸困难的潜在机制：受损的肺泡弥散能力
Masatake Kobayashi,Nicolas Girerd
Masatake Kobayashi
Beyond global longitudinal strain: What else is hidden in the echocardiographic signal? [0.03%]
超越全球纵向应变：心超信号中还隐藏着什么？
Erwan Donal,Layal Mansour,Adrien Al Wazzan
Erwan Donal
Use of cangrelor in patients with reduced renal function: Post-hoc analysis from the ARCANGELO study [0.03%]
肾功能不全患者使用坎格瑞洛的疗效和安全性：ARCANGELO研究的事后分析
Piera Capranzano,Paolo Calabrò,Giuseppe Musumeci et al.
Piera Capranzano et al.
Background: The use of cangrelor in patients with reduced renal function has never been investigated. This post-hoc analysis of the itAlian pRospective Study on CANGrELOr (ARCANGELO) study aims to assess bleeding and isch...
Left atrial mechanical dispersion as a novel predictor biomarker of new-onset atrial arrhythmias in cardiac amyloidosis [0.03%]
左心房机械分散度可作为心脏淀粉样变性新发房颤的预测标志物
Robert Adam,Gabriela Neculae,Sorina Bădeliță et al.
Robert Adam et al.
Aims: We aimed to investigate which parameters of left atrial (LA) structure and function could predict new-onset atrial arrhythmias (NOAA) in patients with CA, aiding in improved follow-up. ...
Diverging drajectories of cardiorenal protection: From early benefit to late attenuation with multifactorial target achievement across cardiovascular-kidney-metabolic syndrome stages [0.03%]
心肾保护的分化轨迹：从早期获益到晚期效应衰减以及心血管-肾脏-代谢综合征阶段多因素靶点的实现之间的关系
Lu Cai,Baiyi Liang,Shiyu Zhou et al.
Lu Cai et al.
Background: The extent to which achieving multiple metabolic treatment targets confers sustained cardiorenal protection across all stages of cardiovascular - kidney - metabolic (CKM) syndrome remains uncertain. ...
Editorial of "Sex difference in clinically suspected immune checkpoint inhibitor-related myocarditis: a single-institute retrospective study with seven-year follow-up" to International Journal of Cardiology [0.03%]
“免疫检查点抑制剂相关心肌炎的临床疑似病例的性别差异：单中心7年回顾性研究”的社论（发表于《国际心脏病学杂志》）
Alessia Fausta Trezza,Andrea Villatore,Giovanni Peretto
Alessia Fausta Trezza